S 1214 · 118th Congress
RARE Act
The RARE Act clarifies how long pharmaceutical companies get exclusive rights to sell drugs designed for rare diseases. When a drug is approved to treat a rare disease, the FDA currently gives the company a seven-year period where no competitor can sell the same drug for that disease. However, there's been confusion…
- Sponsor
- Baldwin, Tammy (D-WI)
- Introduced
- 2023-04-19
- Policy area
- Health
- Latest action
- Placed on Senate Legislative Calendar under General Orders. Calendar No. 109.
Digging through Congress... 🔍